Scientific Industries INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Scientific Industries, Inc. reported a significantly reduced net loss for fiscal year 2025, driven by the sale of its Genie product line and continued investment in its Bioprocessing Systems segment.
OTC.Pink
Scientific Industries reports a decrease in net loss for fiscal year 2024, driven by cost reductions in its Bioprocessing Systems operations, while navigating challenges in its Benchtop Laboratory Equipment segment.
OTC.Pink
Scientific Industries files an amendment to its annual report to include cybersecurity disclosures, while also providing a detailed overview of its financial performance and business operations.
OTC.Pink
Scientific Industries, Inc. reported its full year 2023 results, highlighting a slight revenue increase and ongoing investments in its bioprocessing segment despite continued losses.